ResMed, a developer, manufacturer and distributor of sleep and respiratory medical equipment, has presented the results of a clinical study confirming that patients' compliance with sleep therapy increases when using its new CPAP device.

The clinical study of 50 patients suffering from sleep apnea showed an improvement of 30 minutes in average daily usage, from a mean of 6 hours 35 minutes on the patient’s usual CPAP device, to 7 hours 5 minutes, when using the new S9 Series.

ResMed has developed new improved features for its S9 Series including reduced noise, improved humidification system, and a more comfortable breathing system.

According to the study, from the patients using ResMed’s new sleep apnea therapy platform, 78% preferred the S9 Series over their current device due to comfort of breathing, dryness of nose and mouth, rainout and noise.

ResMed Global Sleep Business Unit senior vice president Michael Farrell said that for the first time with their new ClimateControl system, air is delivered quietly and comfortably at the precise temperature and humidity that the sleeping patient, provider, and physician have set.

“S9 Series provides a significant, patient-perceptible difference in comfort; a true leap-forward for sleep apnea therapy,” Farrell said.